N. P. Acar Et Al. , "An immunological and transcriptomics approach on differential modulation of NK cells in multiple sclerosis patients under interferon-beta 1 and fingolimod therapy," JOURNAL OF NEUROIMMUNOLOGY , vol.347, 2020
Acar, N. P. Et Al. 2020. An immunological and transcriptomics approach on differential modulation of NK cells in multiple sclerosis patients under interferon-beta 1 and fingolimod therapy. JOURNAL OF NEUROIMMUNOLOGY , vol.347 .
Acar, N. P., Tuncer, A., Ozkazanc, D., Ozbay, F. G., KARAOSMANOĞLU, B., Goksen, S., ... Sayat, G.(2020). An immunological and transcriptomics approach on differential modulation of NK cells in multiple sclerosis patients under interferon-beta 1 and fingolimod therapy. JOURNAL OF NEUROIMMUNOLOGY , vol.347.
Acar, Nazire Et Al. "An immunological and transcriptomics approach on differential modulation of NK cells in multiple sclerosis patients under interferon-beta 1 and fingolimod therapy," JOURNAL OF NEUROIMMUNOLOGY , vol.347, 2020
Acar, Nazire P. Et Al. "An immunological and transcriptomics approach on differential modulation of NK cells in multiple sclerosis patients under interferon-beta 1 and fingolimod therapy." JOURNAL OF NEUROIMMUNOLOGY , vol.347, 2020
Acar, N. P. Et Al. (2020) . "An immunological and transcriptomics approach on differential modulation of NK cells in multiple sclerosis patients under interferon-beta 1 and fingolimod therapy." JOURNAL OF NEUROIMMUNOLOGY , vol.347.
@article{article, author={Nazire Pinar Acar Et Al. }, title={An immunological and transcriptomics approach on differential modulation of NK cells in multiple sclerosis patients under interferon-beta 1 and fingolimod therapy}, journal={JOURNAL OF NEUROIMMUNOLOGY}, year=2020}